Publications by authors named "Firas Safa"

Claim this Profile
L
Large B-cell lymphoma: The LYSA pragmatic guidelines.
Pierre Sesques, Guillaume Manson, Sydney Dubois, Francois Xavier Gros, Gabriel Brisou, Firas Safa

Eur J Cancer· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow metastasis of rhabdomyosarcoma mimicking high-grade lymphoma in a young man.
Morgane Le Gallo, Johann Rose, Firas Safa, Laurane Cottin, Baptiste Sourty

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.
Firas M Safa, Terri Rasmussen, Lorena Fontan, Min Xia, Ari Melnick, Hana Safah

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications.
Leigh Deshotels, Firas M Safa, Nakhle S Saba

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and characterization of a new mantle cell lymphoma cell line with a NOTCH2 mutation, Arbo.
Firas Safa, Terri Rasmussen, Patricia Lobelle-Rich, Stephanie Collier, Nicholas Milligan, Hana Safah

EJHaem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.
Jérôme Paillassa, Firas Safa, Xavier Troussard

Ther Adv Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response to erythropoietin for anemia in NK-cell large granular lymphocytosis: A brief case report.
Tendai Kwaramba, Brian Lewis, Bruce Burks, Bernardo Ruiz, Swaminathan P Iyer, Firas Safa

Leuk Res Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel biologic therapies in relapsed or refractory diffuse large B cell lymphoma: CAR-T is not the only answer.
Jérôme Paillassa, Firas Safa

Leuk Res Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.
Alex Niu, Bo Ning, Francisco Socola, Hana Safah, Tim Reynolds, Firas Safa

Leuk Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review.
Houssein Safa, Monica Tamil, Philippe E Spiess, Brandon Manley, Julio Pow-Sang, Firas Safa

J Natl Cancer Inst· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma.
Alex Niu, April McDougal, Bo Ning, Firas Safa, Alfred Luk, Hana Safah

Bone Marrow Transplant· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy.
Gautam Kishore Valecha, Adarsh Vennepureddy, Uroosa Ibrahim, Firas Safa, Bachar Samra

Expert Rev Anticancer Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis